触媒制药 CPRX 深 沪
等待开盘 09-20 09:30:00 美东时间
21.35
+0.920
+4.50%
华盛通- 最 高21.36
- 今 开20.90
- 成交量 115.26万股
- 最 低 20.78
- 昨 收 20.43
- 总市值 25.19亿
- 52周最高 21.36
- 市盈率 静 34.01
- 换手率 0.98%
- 52周最低 11.55
- 委 比 -70.30%
- 总股本 1.18亿
- 历史最高 22.11
- 量 比 1.19
- 振 幅 2.84%
- 历史最低 0.37
- 每 手 1
- 风险率 2.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Dyne stock tumbles 31% amid drug updates, management changes
Shares of Dyne Therapeutics (NASDAQ:DYN) fell 31% Tuesday after the company released new data from a clinical trial called DELIVER for its drug DYNE-251 in the treatment of Duchenne muscular dystrophy...
09-04 04:48
新浪财经ESG：Catalyst Pharmaceutical Partners 路孚特（Refinitiv）ESG评级调升至B-
新浪财经ESG评级中心提供包括资讯、报告、培训、咨询等在内的14项ESG服务，助力上市公司传播ESG理念，提升ESG可持续发展表现。点击查看【 ESG评级中...
08-19 07:01
Top 3 Health Care Stocks That May Crash In August
As of Aug 14, 2024, three stocks in the health care sector could be flashing a ...
08-14 20:35
快讯 | Catalyst Pharmaceuticals：H.c. Wainwright将目标价从26美元提高至30美元。
Catalyst Pharmaceuticals : H.c. Wainwright Raises Target Price to $30 From $26
08-12 18:16
Piper lists eight defensive biotechs to face market volatility
With market volatility becoming a common phenomenon, Piper Sandler showcased eight "high-quality" defensive growth stocks in the biopharma space this week. Its comments came after a global sell-off of...
08-11 02:29
Citigroup Maintains Buy on Catalyst Pharmaceuticals, Raises Price Target to $31
Citigroup analyst Samantha Semenkow maintains Catalyst Pharmaceuticals (NASDAQ:CPRX) with a Buy and raises the price target from $27 to $31.
08-10 06:42
快讯 | catalyst pharmaceuticals股票成交量激增至$17.58，股价跌至当日最低点，最新报价下跌0.9％，至$18.13
Catalyst Pharmaceuticals Shares Fall to Session Low of $17.58 in Volume Jump, L...
08-10 02:10
快讯 | catalyst pharmaceuticals公司: 花旗集团将目标价从27美元上调至31美元
Catalyst Pharmaceuticals Inc : Citigroup Raises Target Price to $31 From $27
08-09 18:50
Catalyst Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 financial results.
Catalyst Pharmaceuticals shares are trading higher after the company reported b...
08-09 02:20
快讯 | catalyst pharmaceuticals公司二季度每股收益为0.26美元——LSEG IBES数据
Catalyst Pharmaceuticals Inc Q2 Shr View $0.26 -- LSEG IBES Data
08-08 04:13
